Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Karyopharm Therapeutics

Jul 18, 2023

Lilly to Acquire Versanis; FDA Approves Beyfortus for RSV in Infants; Alnylam Presented Updates on Interim Phase 1 Results for ALN-APP; FDA Accepts NDA for Rivoceranib Plus Camrelizumab; FDA Fast Track Designation to Karyopharm’s Selinexor; Adcentrx’s IND Application for ADRX-0706

Mar 10, 2020

Soft Tissue Sarcoma Treatment Market: Present treatment approaches and Unmet Needs

Mar 06, 2020

Soft Tissue Sarcoma: A rare malignancy

Newsletter/Whitepaper